Revital Nimri

Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel.

Continuing Medical Education, Inc. is based in San Diego, CA. Part of The Nielsen Company (US) LLC, Continuing Medical Education, Inc. is a company that publishes medical magazines and journals. Continuing Medical Education was acquired by Miller Freeman, Inc., part of The Nielsen Company (US) LLC from July 18, 2000 on March 26, 1999 for $111 million.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel.

BioJerusalem engages in the provision of financial assistance to life sciences companies choosing to launch operations in Jerusalem, which are eligible for prime financial support incentives and are given special preference. The company is headquartered in Jerusalem, Israel.

KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel.

Dynamix Pharmaceuticals Ltd. discovers and develops small-molecule drugs for treating cancer and autoimmune disorders. It focuses its discovery on cancer metabolism modulators and type II selective kinase inhibitors. The firm offers DNX-03000 that targets Pyruvate Kinase M2 (PKM2), an enzyme that is a key mediator of cancer metabolism; and DNX-06000 that targets an undisclosed target. The company was founded by Oren M. Becker in 2009 and is headquartered in Rehovot, Israel.

Medicine On Line Israel (Moli) Ltd. is engaged in the field of diabetes . It focuses on: Improving the quality of life and medical treatment for people with diabetes, Performing educational activities, Producing scientific publications, and training people with diabetes. The association was founded by Ludwig Nelken, Herman Wolfson, Dr Liven, and Prof. A. M. Cohen in 1954 and is headquartered in Rishon Le-Zion, Israel.

Institute of Endocrinology & Diabetes engages in medical services. The company is headquartered in Westmead, Australia.

OurCrowd Management Ltd (OurCrowd) is a venture capital firm founded in 2013 by Jonathan Medved and Steven Blumgart. The firm is headquartered in Jerusalem, Israel.

HIL Applied Medical Ltd. develops cancer Proton Therapy systems. It applies a patented approach, combining nanotechnology, and high-intensity lasers for its solutions. The company was founded by Shmuel Eisenmann and Arie Zigler in 2010 and is headquartered in Jerusalem, Israel.

FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona.

Nanolabz, Inc. develops a technology system for cancer proton radiation therapy. It develops and sells laser physics targets for the short-pulse laser research and development sector. The company was founded by Steven Malekos, Jesse Adams, and Grant Korgan and is headquartered in Sparks, NV.

ImmPACT-Bio Ltd. develops therapies to treat cancer. Its chimeric antigen receptor T-cell (CAR-T) therapy addresses the need to differentiate cancerous from non-cancerous tissues. The company was founded by Gideon Gross in April 2017 and is headquartered in Nes Ziona, Israel.

BrainQ Technologies Ltd. develops a detection and non-invasive treatment technology to help patients with paralysis move their limbs. The company was founded by Segal Yaron, Drechsler Yotam, and Shohami Emerita Esther on August 14, 2011 and is headquartered in Jerusalem, Israel.

OurCrowd Medtech Fund invests in companies located in Israel. The fund targets operating in the fields of medical devices, therapeutics, medical robotics. It provides financing for early stage capital requirements.

OncoHost Ltd. is an Israeli technology company that combines life-science research and advanced machine learning technology to develop personalized strategies to maximize the success of cancer therapy. The company utilizes proprietary proteomic analysis to understand a patient's unique response to therapy and overcome resistance to therapy. OncoHost's host response profiling platform (Prophet®) analyzes proteomic changes in blood samples to monitor the dynamics of biological processes induced by the patient in response to a given cancer therapy. OncoHost was founded in 2017, and the CEO is Ofer Sharon.

Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel.